NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/15/2023
Back to search
Official data from USPTO
COLVERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COLVERA
ST13
US500000087112716Class
10, 42, 44
Filing
87112716
Registration
5304460
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
11/15/2023
Trademark type
Word
Nice classes
10, 42, 44
Filing date
07/22/2016
Registration date
10/10/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2023
Last transaction
11/15/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
NORTH RYDE, NSW, AU
Examiner
SANDER, DREW
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
Clinical Genomics Pty Ltd
Clinical Genomics Pty Ltd
Representatives
Sarah W. Matthews Dentons Durham Jones Pinegar
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Apparatus for the withdrawal of blood for medical test purposes; Apparatus for blood analysis; Blood testing apparatus; Apparatus for carrying-out medical diagnostic tests for testing blood for the presence of genes associated with cancer; medical apparatus for use in blood test procedures; Medical diagnostic apparatus in kit form for testing blood for the presence of genes associated with cancer; Medical apparatus for use in in-vitro diagnosis of blood; Diagnostic apparatus for medical purposes for the detection of cancer; Medical diagnostic testing apparatus for testing blood for the presence of genes associated with cancer; Scientific apparatus for use in medical diagnostic applicationsfor use in diagnosing cancer; Blood testing medical apparatus in kit form; Medical diagnostic instruments for testing blood for the presence of genes associated with cancer; Medical diagnostic instruments for the analysis of body fluids; Tools for medical diagnosismedical diagnostic apparatus for testing blood for the presence of genes associated with cancer; Instruments for medical diagnosis namelymedical diagnostic apparatus for testing blood for the presence of genes associated with cancer
Class 42
Scientific laboratory services; Technical diagnostic testing services in the field of medical diagnostic equipment; Medical laboratory testing services; Medical research; Research and development of new products; Laboratory research in the field of genetics; Scientific research relating to molecular sciences; Scientific research; Scientific research into the development of new products; Scientific research relating to genetics; Providing advice in the field of technical diagnostic products; Biotechnologyresearchtesting; DNA analysis servicestesting for scientific research purposes; Development of diagnostic test equipment; conducting clinical trials for others
Class 44
Medical diagnostic servicestesting and analysis in the field of genetics and cancer; Medical health assessment services; Medical screening; Medical services; Provision of medical information; Medical advisory services relating to diseases; Medical advisory services relating to health; Health care; Health screening in the field of cancer; Services for the testing of blood; medical services in the field of pathology
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/14/2023
E815
TEAS SECTION 8 & 15 RECEIVED
05/16/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2017
PUBO
PUBLISHED FOR OPPOSITION
07/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2017
ALIE
ASSIGNED TO LIE
05/17/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
11/03/2016
GPRA
PRIORITY ACTION E-MAILED
11/03/2016
CPRA
PRIORITY ACTION WRITTEN
11/03/2016
DOCK
ASSIGNED TO EXAMINER
11/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/27/2016
NWAP
NEW APPLICATION ENTERED
07/26/2016
Continuous trademark protection
Get notified about every new filing that threatens COLVERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.